Skip to main content
. Author manuscript; available in PMC: 2019 Oct 29.
Published in final edited form as: Gynecol Oncol. 2019 Mar 6;153(2):242–247. doi: 10.1016/j.ygyno.2019.03.001

Table 3.

Adjuvant therapy, recurrence, and survival.

Abdominal radical hysterectomy Robotic radical hysterectomy p-Value

Adjuvant therapy 0.17
  None 37(66%) 40 (82%)
  Radiation 7 (13%) 2 (4%)
  Chemoradiation 12 (21%) 7 (14%)
Recurrence 0.22
  No 48(86%) 37 (76%)
  Yes 8 (14%) 12 (24%)
Recurrence site 0.32
  Vault 3 (5%) 3 (6%)
  Pelvis 1 (2%) 0 (0%)
  Abdomen 1 (2%) 1 (2%)
  Distant 0 (0%) 0 (0%)
  Multiple 3 (5%) 8 (16%)
Death 0.18
  No 53(95%) 42 (86%)
  yes 3 (5%) 7 (14%)
  Tumor size < 2 cm Tumor size ≥ 2 cm p-Value

Recurrence 0.006
  No   47 (92%) 38 (70%)
  yes   4 (8%) 16 (30%)
Death 0.09
  No   49 (96%) 46 (85%)
  Yes   2 (4%) 8 (15%)

Bold indicates p-Value of < 0.05